Used in pharmaceutical research as a potent histone deacetylase (HDAC) inhibitor, particularly targeting HDAC6 isoform. Shows promise in development of anticancer agents due to its ability to induce apoptosis and inhibit tumor cell proliferation. Demonstrates anti-inflammatory and neuroprotective properties, making it a candidate for neurodegenerative disease studies such as Alzheimer’s and Parkinson’s. Also investigated for antiparasitic activity, especially against protozoan infections like leishmaniasis. Its selective binding and metabolic stability support use in designing targeted therapies with reduced off-target effects.